SCHEMBL2874197

SCHEMBL2874197

CC1CCC(C(=O)N(c2cc(-c3ccc(F)cc3)sc2OC(=O)O)C(C)C)C(O)C1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 3/20 0.35
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
MMP13 P45452 1/20 0.31
MMP14 P50281 1/20 0.31
CNR1 P21554 1/20 0.30
CNR2 P34972 1/20 0.30
GPR88 Q9GZN0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2879577 0.92 GPR88 (0.33) GPR88
SCHEMBL3811154 0.92 TRPV1 (0.37) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL3809541 0.92 TRPV1 (0.37) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL3811193 0.92 TRPV1 (0.37) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL2878984 0.90 TRPM8 (0.38) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL3814842 0.88 IKBKB (0.38) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL2871046 0.87 IKBKB (0.41) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL2878950 0.87 IKBKB (0.41) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL6266218 0.87 IKBKB (0.41) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL3811209 0.83 TRPV1 (0.37) KDM4ENPC1MAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569929-B9 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2011-09-14 EP claimed
EP-1569929-B1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2010-05-05 EP claimed